SE9102074D0 - Tomour antigen specific antibody - Google Patents
Tomour antigen specific antibodyInfo
- Publication number
- SE9102074D0 SE9102074D0 SE9102074A SE9102074A SE9102074D0 SE 9102074 D0 SE9102074 D0 SE 9102074D0 SE 9102074 A SE9102074 A SE 9102074A SE 9102074 A SE9102074 A SE 9102074A SE 9102074 D0 SE9102074 D0 SE 9102074D0
- Authority
- SE
- Sweden
- Prior art keywords
- tomour
- antibody
- specific antibody
- antigen specific
- antigen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1063—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1057—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from liver or pancreas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/303—Liver or Pancreas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3046—Stomach, Intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9102074A SE9102074D0 (sv) | 1991-07-03 | 1991-07-03 | Tomour antigen specific antibody |
IL10239092A IL102390A (en) | 1991-07-03 | 1992-07-02 | Antibody specific for malignant tumors, its use and cell lines that produce this antibody |
PCT/SE1992/000495 WO1993001302A1 (en) | 1991-07-03 | 1992-07-02 | Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
PCT/SE1992/000502 WO1993001303A1 (en) | 1991-07-03 | 1992-07-03 | Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
JP17584892A JP3194020B2 (ja) | 1991-07-03 | 1992-07-03 | 腫瘍抗原特異的抗体、それを含む医薬組成物およびその抗体を産生する細胞系 |
NZ243435A NZ243435A (en) | 1991-07-03 | 1992-07-03 | Monoclonal antibody specific for a tumour antigen, its use and the cell line responsible for its production |
DE69226990T DE69226990T2 (de) | 1991-07-03 | 1992-07-03 | Tumorantigen-spezifischer Antikörper |
AU19425/92A AU658198B2 (en) | 1991-07-03 | 1992-07-03 | Tumour antigen specific antibody, its use and cell in line producing the antibody |
AT92850166T ATE171193T1 (de) | 1991-07-03 | 1992-07-03 | Tumorantigen-spezifischer antikörper |
DK92850166T DK0521842T3 (da) | 1991-07-03 | 1992-07-03 | Tumorantigenspecifikt antistof |
EP92850166A EP0521842B1 (en) | 1991-07-03 | 1992-07-03 | Tumor antigen specific antibody |
KR1019930704117A KR100246681B1 (ko) | 1991-07-03 | 1992-07-03 | 종양, 탄수화물 항원에 특이한 모노클로날 항체 및 세포계 |
HU9400011A HU218084B (hu) | 1991-07-03 | 1992-07-03 | Daganatokra specifikus monoklonális antitest és sejtvonal, valamint ezeket tartalmazó gyógyászati készítmények |
ES92850166T ES2124250T3 (es) | 1991-07-03 | 1992-07-03 | Anticuerpo especifico para un antigeno tumoral. |
CA002073124A CA2073124C (en) | 1991-07-03 | 1992-07-03 | Tumor antigen specific antibody |
AU22920/92A AU2292092A (en) | 1991-07-03 | 1992-07-03 | Tumor, carbohydrate antigen specific monoclonal antibody and cell line |
IE922188A IE80841B1 (en) | 1991-07-03 | 1992-07-03 | Tumor antigen specific antibody |
NO19934777A NO315472B1 (no) | 1991-07-03 | 1993-12-22 | Tumor, karbohydratantigen spesifikt monoklonalt antistoff og cellelinje, farmasöytisk sammensetning og fremgangsmåte for invitro diagnostikk |
FI935970A FI109207B (fi) | 1991-07-03 | 1993-12-31 | Tuumori/hiilihydraattiantigeenispesifinen monoklonaalinen vasta-aine ja solulinja |
EE9400328A EE03031B1 (et) | 1991-07-03 | 1994-11-16 | Kasvaja süsivesik-antigeeni spetsiifiline monokloonne antikeha, meetod in vitro diagnostikaks ja farmatseutilised kompositsioonid |
US08/438,123 US5552293A (en) | 1991-07-03 | 1995-05-08 | Tumor antigen specific antibody |
HU95P/P00289P HU211512A9 (en) | 1991-07-03 | 1995-06-20 | Tumor antigen specific antibody and cell line, and pharmaceutical composition comprising them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9102074A SE9102074D0 (sv) | 1991-07-03 | 1991-07-03 | Tomour antigen specific antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9102074D0 true SE9102074D0 (sv) | 1991-07-03 |
Family
ID=20383243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9102074A SE9102074D0 (sv) | 1991-07-03 | 1991-07-03 | Tomour antigen specific antibody |
Country Status (19)
Country | Link |
---|---|
US (1) | US5552293A (hu) |
EP (1) | EP0521842B1 (hu) |
JP (1) | JP3194020B2 (hu) |
KR (1) | KR100246681B1 (hu) |
AT (1) | ATE171193T1 (hu) |
AU (2) | AU658198B2 (hu) |
CA (1) | CA2073124C (hu) |
DE (1) | DE69226990T2 (hu) |
DK (1) | DK0521842T3 (hu) |
EE (1) | EE03031B1 (hu) |
ES (1) | ES2124250T3 (hu) |
FI (1) | FI109207B (hu) |
HU (2) | HU218084B (hu) |
IE (1) | IE80841B1 (hu) |
IL (1) | IL102390A (hu) |
NO (1) | NO315472B1 (hu) |
NZ (1) | NZ243435A (hu) |
SE (1) | SE9102074D0 (hu) |
WO (2) | WO1993001302A1 (hu) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9402430L (sv) | 1994-07-11 | 1996-01-12 | Pharmacia Ab | Konjugat mellan modifierat superantigen och en målsökande förening samt användning av konjugaten |
SE9601245D0 (sv) | 1996-03-29 | 1996-03-29 | Pharmacia Ab | Chimeric superantigens and their use |
TW517061B (en) | 1996-03-29 | 2003-01-11 | Pharmacia & Amp Upjohn Ab | Modified/chimeric superantigens and their use |
EP2266607A3 (en) | 1999-10-01 | 2011-04-20 | Immunogen, Inc. | Immunoconjugates for treating cancer |
EP1411962B1 (en) * | 2001-03-15 | 2011-01-19 | Neogenix Oncology, Inc. | Monoclonal antibody therapy for pancreas cancer |
DE10116552A1 (de) * | 2001-04-03 | 2002-10-10 | Abc Armbruster Biochemicals | Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe |
EP1539239A4 (en) * | 2002-07-02 | 2005-09-14 | Smithkline Beecham Corp | NEW STABLE FORMULATION |
US7390898B2 (en) | 2002-08-02 | 2008-06-24 | Immunogen Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
EP3851126A1 (en) | 2003-05-20 | 2021-07-21 | ImmunoGen, Inc. | Maytansinoid-cell-binding agent conjugates |
AU2006213662B2 (en) * | 2005-02-11 | 2010-08-05 | Immunogen, Inc. | Process for preparing stable drug conjugates |
US20110166319A1 (en) * | 2005-02-11 | 2011-07-07 | Immunogen, Inc. | Process for preparing purified drug conjugates |
NZ566245A (en) * | 2005-08-11 | 2012-04-27 | Matossian Rogers Arpi | Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
AU2012244244B2 (en) * | 2005-08-11 | 2015-08-27 | Arpi Matossian-Rogers | TCR-V-beta related peptides for treatment and diagnosis of autoimmune disease |
ES2533992T3 (es) | 2005-08-24 | 2015-04-16 | Immunogen, Inc. | Procedimiento para preparar conjugados de anticuerpo maitansinoide |
RU2519089C2 (ru) | 2008-08-05 | 2014-06-10 | Торэй Индастриз, Инк. | Способ обнаружения злокачественных опухолей |
KR102444399B1 (ko) | 2009-06-03 | 2022-09-16 | 이뮤노젠 아이엔씨 | 메이탄시노이드의 제조방법 |
MY171008A (en) | 2011-03-29 | 2019-09-23 | Immunogen Inc | Preparation of maytansinoid antibody conjugates by a one-step process |
UA116524C2 (uk) | 2011-03-29 | 2018-04-10 | Іммуноджен, Інк. | Спосіб одержання кон'югата антитіло-майтансиноїд |
RU2661083C2 (ru) | 2012-10-04 | 2018-07-11 | Иммуноджен, Инк. | Использование пвдф-мембраны для очистки конъюгатов клеточно-связывающий агент - цитотоксический агент |
WO2015076425A1 (ja) * | 2013-11-25 | 2015-05-28 | リンク・ジェノミクス株式会社 | 新規モノクローナル抗体 |
CA2966932A1 (en) | 2014-11-19 | 2016-05-26 | Immunogen, Inc. | Process for preparing cell-binding agent-cytotoxic agent conjugates |
JP7161938B2 (ja) | 2016-01-10 | 2022-10-27 | ネオティーエックス セラピューティクス リミテッド | スーパー抗原媒介性癌免疫療法の能力を増強するための方法および組成物 |
EP3411077A1 (en) | 2016-02-05 | 2018-12-12 | ImmunoGen, Inc. | Efficient process for preparing cell-binding agent-cytotoxic agent conjugates |
CN107167590B (zh) * | 2017-04-14 | 2019-03-08 | 江苏福隆生物技术有限公司 | 糖类抗原242的板式化学发光法检测试剂盒及制备方法 |
US20200256880A1 (en) * | 2017-08-16 | 2020-08-13 | The Broad Institute, Inc. | Neuronal Assay Method Involving Calcineurin |
MX2021013908A (es) | 2019-05-15 | 2022-03-11 | Neotx Therapeutics Ltd | Tratamiento para el cáncer. |
KR20220150353A (ko) | 2020-03-05 | 2022-11-10 | 네오티엑스 테라퓨틱스 엘티디. | 면역 세포를 사용하여 암을 치료하기 위한 방법 및 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4752569A (en) * | 1984-06-21 | 1988-06-21 | The Regents Of The University Of California | Sialylated Lewisx epitope, antibodies and diagnosis |
US4904596A (en) * | 1985-08-07 | 1990-02-27 | Fred Hutchinson Cancer Research Center | Hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside |
SE8902043L (sv) * | 1988-11-10 | 1990-05-11 | Pharmacia Ab | Foerfarande foer karakterisering av makromolekyler |
DK0610179T3 (da) * | 1990-07-20 | 1997-03-24 | Pharmacia & Upjohn Ab | Målspecifikke antistof-superantigenkonjugater og fremstilling deraf |
EP0540612A1 (en) * | 1990-07-20 | 1993-05-12 | Pharmacia AB | Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
-
1991
- 1991-07-03 SE SE9102074A patent/SE9102074D0/xx unknown
-
1992
- 1992-07-02 IL IL10239092A patent/IL102390A/en not_active IP Right Cessation
- 1992-07-02 WO PCT/SE1992/000495 patent/WO1993001302A1/en active Search and Examination
- 1992-07-03 KR KR1019930704117A patent/KR100246681B1/ko not_active IP Right Cessation
- 1992-07-03 DK DK92850166T patent/DK0521842T3/da active
- 1992-07-03 WO PCT/SE1992/000502 patent/WO1993001303A1/en active IP Right Grant
- 1992-07-03 AT AT92850166T patent/ATE171193T1/de not_active IP Right Cessation
- 1992-07-03 HU HU9400011A patent/HU218084B/hu not_active IP Right Cessation
- 1992-07-03 NZ NZ243435A patent/NZ243435A/en not_active IP Right Cessation
- 1992-07-03 AU AU19425/92A patent/AU658198B2/en not_active Ceased
- 1992-07-03 IE IE922188A patent/IE80841B1/en not_active IP Right Cessation
- 1992-07-03 ES ES92850166T patent/ES2124250T3/es not_active Expired - Lifetime
- 1992-07-03 JP JP17584892A patent/JP3194020B2/ja not_active Expired - Lifetime
- 1992-07-03 AU AU22920/92A patent/AU2292092A/en not_active Abandoned
- 1992-07-03 CA CA002073124A patent/CA2073124C/en not_active Expired - Lifetime
- 1992-07-03 EP EP92850166A patent/EP0521842B1/en not_active Expired - Lifetime
- 1992-07-03 DE DE69226990T patent/DE69226990T2/de not_active Expired - Lifetime
-
1993
- 1993-12-22 NO NO19934777A patent/NO315472B1/no unknown
- 1993-12-31 FI FI935970A patent/FI109207B/fi not_active IP Right Cessation
-
1994
- 1994-11-16 EE EE9400328A patent/EE03031B1/xx not_active IP Right Cessation
-
1995
- 1995-05-08 US US08/438,123 patent/US5552293A/en not_active Expired - Lifetime
- 1995-06-20 HU HU95P/P00289P patent/HU211512A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HU211512A9 (en) | 1995-11-28 |
DK0521842T3 (da) | 1999-06-14 |
KR100246681B1 (ko) | 2000-04-01 |
ATE171193T1 (de) | 1998-10-15 |
NZ243435A (en) | 1994-10-26 |
AU1942592A (en) | 1993-01-07 |
EP0521842A3 (hu) | 1994-01-26 |
WO1993001303A1 (en) | 1993-01-21 |
HUT71193A (en) | 1995-11-28 |
IL102390A (en) | 1996-01-19 |
NO315472B1 (no) | 2003-09-08 |
EP0521842A2 (en) | 1993-01-07 |
DE69226990T2 (de) | 1999-03-25 |
IE922188A1 (en) | 1993-01-13 |
AU658198B2 (en) | 1995-04-06 |
IE80841B1 (en) | 1999-03-24 |
IL102390A0 (en) | 1993-01-14 |
FI935970A0 (fi) | 1993-12-31 |
NO934777L (no) | 1994-02-11 |
HU9400011D0 (en) | 1994-05-30 |
ES2124250T3 (es) | 1999-02-01 |
DE69226990D1 (de) | 1998-10-22 |
CA2073124A1 (en) | 1993-01-04 |
CA2073124C (en) | 2007-06-19 |
EP0521842B1 (en) | 1998-09-16 |
FI935970A (fi) | 1993-12-31 |
HU218084B (hu) | 2000-05-28 |
WO1993001302A1 (en) | 1993-01-21 |
US5552293A (en) | 1996-09-03 |
JP3194020B2 (ja) | 2001-07-30 |
FI109207B (fi) | 2002-06-14 |
JPH05276987A (ja) | 1993-10-26 |
AU2292092A (en) | 1993-02-11 |
NO934777D0 (no) | 1993-12-22 |
EE03031B1 (et) | 1997-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9102074D0 (sv) | Tomour antigen specific antibody | |
FI101937B1 (fi) | Menetelmä monoklonaalisen vasta-aineen tuottamiseksi, joka reagoi ihmisen cachectiinin kanssa | |
MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
DE69127487T2 (de) | Verfahren zum Nachweis der Alzheimer-Krankheit | |
DE3684211D1 (hu) | ||
DE3688204T2 (de) | Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens. | |
DE69015230D1 (de) | Antikörper gegen menschliches Sperma, ihre Herstellung und Anwendung. | |
DE3850993D1 (de) | Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2. | |
DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
RU93058456A (ru) | Антитела, способы диагностики, способ лечения, фармацевтическая композиция, клеточные линии | |
DE69124317T2 (de) | Monoklonale Antikörper gegen Leptosphaeria | |
DE69118827D1 (de) | Antikörper gegen Hamsterimmunglobulinen | |
IT8020164A0 (it) | Procedimento per produrre colture sporifere di un ceppo di clavicepspurpurea virulento sulla segale e producente l'ergocristina. | |
DK182188A (da) | Humant tumorassocieret antigen |